| Latest Laboratory Corporation News Headlines | | Date | Time | Source | | | 08/28/2009 | 5:41PM | PRNUS | BetterInvesting Magazine Releases November Stock to Study and Undervalued Stock Choices for Investors' Informational and Educati
MADISON HEIGHTS, Mich. Aug. 28 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Laboratory Corporation of America Holdings (NYSE:LH) as its November 2009 "Stock to Study" and Genzyme Corporation (NASDAQ:GENZ) as its November "Undervalued Stock" for investors... More...>> |
| 02/18/2009 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on GOOG, CHK, MRVL, DV, and LH
CHICAGO, Feb. 18 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/021809B (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 10/28/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on HD, AMGN, NUE, FDX, and LH
CHICAGO, Oct. 28 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at
http://www.iotogo.com/s/102808B (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 10/22/2008 | 9:20AM | PRNUS | Beacon Equity Issues Technical Trade Alerts on Medical Laboratories and Research Stocks: DGX, ERES, LH, PPDI, BRLI, CVD
DALLAS, Oct. 22 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's Trade Alerts include: Quest Diagnostics Inc. (NYSE:DGX), eResearch Technology Inc. (NASDAQ:ERES... More...>> |
| 09/23/2008 | 7:00AM | PRNUS | FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
BROOMFIELD, Colo., Sept. 23 /PRNewswire/ -- ARCA biopharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for the company's lead product candidate, bucindolol, an investigational and pharmacologically unique beta-blocker and mild vasodilator developed... More...>> |
| 09/22/2008 | 9:00AM | PRNUS | Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
Common Genetic Variations Predict Patient Response to Novel Beta Blocker Therapy
TORONTO, Sept. 22 /PRNewswire/ -- Bucindolol, an investigational, pharmacologically unique beta-blocker and mild vasodilator, significantly reduces hospitalization and death among heart failure patients with very favorable genotypes, according... More...>> |
| 06/05/2008 | 7:00AM | PRNUS | LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
BURLINGTON, N.C. and ROCKVILLE, M.D., June 5 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), one of the world's leading clinical trials and genetic testing laboratories, and Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), a biopharmaceutical company focused on the development... More...>> |
| 04/23/2008 | 9:00AM | PRNUS | SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond... More...>> |
| 10/22/2007 | 7:00AM | PRNUS | Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
Collaboration to Explore Clinical Uses of Personal Genetics and Tamoxifen
FRANKLIN LAKES, NJ and BURLINGTON, NC, Oct. 22 /PRNewswire-FirstCall/ -- Medco Health Solutions Inc. (NYSE:MHS) and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced a strategic research agreement today to advance... More...>> |
| 07/24/2007 | 7:26AM | PRNUS | Laboratory Corporation of America(R) Holdings Announces 2007 Second Quarter Results
Second Quarter Net Sales Growth of 15.4% Drives EPS Increase of 20.7%
BURLINGTON, N.C., July 24 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced results for the quarter and six months ended June 30, 2007.
Second Quarter Results
Net earnings increased 10.5... More...>> |
| 07/16/2007 | 7:45AM | PRNUS | Third Wave to Collaborate with LabCorp on Development of Companion Diagnostic to Personalize Treatment of Heart Failure
MADISON, Wis., July 16 /PRNewswire-FirstCall/ -- Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that it has signed a pharmacogenetics collaboration agreement with Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), one of the world's largest reference laboratories and a pioneer in commercializing... More...>> |
| 05/16/2007 | 2:41PM | PRNUS | CheckUps Clinics to Provide Specimen Collection Services for LabCorp
NEW YORK, May 16 /PRNewswire/ -- CheckUps, the retail-based, non-emergency walk-in medical facility, and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), today announced an agreement under which CheckUps clinics will perform specimen collections for LabCorp.
The agreement means that patients whose... More...>> |
| 04/26/2007 | 7:31AM | PRNUS | Laboratory Corporation of America(R) Holdings Announces 2007 First Quarter Results
First Quarter Net Sales Growth of 13.7% Drives Operating Cash Flow of $185.8 Million and EPS Increase of 28.9%
BURLINGTON, N.C., April 26 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced results for the quarter ended March 31, 2007.
First Quarter Results
Net... More...>> |
| 04/26/2007 | 7:31AM | PRNUS | Laboratory Corporation of America(R) Holdings Announces 2007 First Quarter Results
First Quarter Net Sales Growth of 13.7% Drives Operating Cash Flow of $185.8 Million and EPS Increase of 28.9%
BURLINGTON, N.C., April 26 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced results for the quarter ended March 31, 2007.
First Quarter Results
Net... More...>> |
| 04/25/2007 | 8:00AM | PRNUS | Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Essays
ROCKVILLE, Md. and BURLINGTON, N.C., April 25 /PRNewswire-FirstCall/ -- Celera (NYSE:CRA), an Applera Corporation business, and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), a national leader in esoteric and oncology testing, today announced that they have signed an agreement granting LabCorp... More...>> |
| 04/16/2007 | 5:14PM | PRNUS | Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes D
BURLINGTON, N.C., April 16 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set... More...>> |
| 03/19/2007 | 5:47PM | PRNUS | LabCorp's Liquid Yield Option(TM) Notes Due 2021 And Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Ca
BURLINGTON, N.C., March 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that for the period of March 12, 2007 to September 11, 2007, its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes... More...>> |
| 03/19/2007 | 1:24PM | PRNUS | LabCorp is Scheduled to Present at the Lehman Brothers 2007 Global Healthcare Conference
BURLINGTON, N.C., March 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T. Smith, Executive Vice President, Corporate... More...>> |
| 03/14/2007 | 10:31AM | PRNUS | Seven Summits Research Releases Alerts on AAPL, PFE, NOV, LH, and TTWO
CHICAGO, March 14 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/smu.asp?p=031407A (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts... More...>> |
| 03/13/2007 | 7:26AM | PRNUS | LabCorp Announces $500 Million Stock Repurchase Program
BURLINGTON, N.C., March 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $500,000,000 of its Common Stock from time-to-time.
The... More...>> |
|